Clinical Review
Promoting Tobacco Cessation During Substance Abuse Treatment
Fed Pract. 2011 March;28(3):17
Author and Disclosure Information
Jaime L. Winn, PhD; Suzanne E. Shealy, PhD; Joseph D. Markowitz, MD; Joseph DeBaldo, MBA, MEd; Cheryl Gonzales-Nolas, MD; and Elie Francis, MD
Dr. Winn and Dr. Shealy are clinical psychologists, Dr. Markowitz is an attending psychiatrist, Mr. DeBaldo is an addiction counselor, and Dr. Gonzales-Nolas and Dr. Francis are attending psychiatrists, all at the James A. Haley Veterans' Hospital in Tampa, Florida. In addition, Drs. Winn, Shealy, Markowitz, and Gonzales-Nolas are assistant professors, and Dr. Francis is an associate professor, all at the University of South Florida in Tampa.
Through a retrospective medical record review that includes naturalistic observation data, researchers attempt to determine whether nicotine addiction can be addressed successfully during treatment
for nonnicotine substance use disorders.
In 2007, the prevalence of cigarette smoking among adults in the United States dropped below 20% for the first time since the 1964 publication of the Surgeon General’s report on the hazards of smoking.1,2 Although that statistic represents a continuing decline in cigarette smoking among all sociodemographic groups in the United States, cigarette smoking among individuals with a substance use disorder (SUD) is 3 to 4 times that of the general population,3,4 and, in 1 treatment sample, was reported to be as high as 92%.5